NCT06661746

Brief Summary

Postoperative pain remains a prevalent concern despite ongoing improvements in surgical methods and pain management strategies. Opioids, while commonly prescribed, frequently lead to undesirable side effects. Epidural analgesia, though a viable option, carries its risks and complications. Recent research indicates that combining intravenous lidocaine and ketamine can significantly alleviate postoperative pain and decrease the reliance on opioids within the initial 24 hours following surgery. This approach offers a promising alternative with minimal additional adverse effects, suggesting a potential shift in pain management practices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

4 months

First QC Date

October 25, 2024

Last Update Submit

December 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients reporting at least a 50% reduction in pain (measured by Numerical Rating Scale) in post-Operative follow up.

    Value of Multimodal injection in Pain Reduction post operatively manifested by recurrence of pain.

    3 months

Study Arms (2)

Multimodal Group

ACTIVE COMPARATOR
Drug: Multimodal IV analgesia

Epidural Group

ACTIVE COMPARATOR
Drug: epidural analgesia

Interventions

Multimodal IV analgesia of lidocaine, ketamine and MS

Multimodal Group

Opioid-based and epidural analgesia

Epidural Group

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were assigned for surgical intervention;
  • Patients of ASA grade I-III;

You may not qualify if:

  • Patients who are not in ASA grade I-III;
  • Patients who had uncontrolled hypertension and/or diabetes mellitus;
  • Patients who had uncompensated cardiac, renal, or hepatic diseases;
  • Patients with coagulopathy, spinal deformity, allergy, or contraindication for the used drugs;
  • Patients who refused to sign the informed consent were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benha University

Banhā, El Qalyoubia, 13511, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Analgesia, Epidural

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, Pain & ICU

Study Record Dates

First Submitted

October 25, 2024

First Posted

October 28, 2024

Study Start

July 15, 2024

Primary Completion

October 30, 2024

Study Completion

November 15, 2024

Last Updated

December 24, 2024

Record last verified: 2024-12

Locations